Does alprazolam (Xanax) interfere with a hepatobiliary iminodiacetic acid (HIDA) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Xanax (alprazolam) interferes with HIDA scans and should be withheld before testing.

Benzodiazepines, including alprazolam (Xanax), must be discontinued at least 24 hours prior to a HIDA scan to avoid false-positive results. 1

Why Benzodiazepines Interfere

Benzodiazepines affect gallbladder contraction, which is the critical physiologic function being assessed during HIDA scanning, particularly when cholecystokinin (CCK) stimulation is used to calculate gallbladder ejection fraction (GBEF). The interference mechanism relates to their effect on smooth muscle function and gallbladder motility, which can spuriously decrease GBEF values and lead to misdiagnosis of functional gallbladder disorder.

Specific Medication Withholding Guidelines

According to consensus recommendations from an interdisciplinary panel published in Clinical Gastroenterology and Hepatology, the following medication timing applies 1:

  • Benzodiazepines (including Xanax): Withhold for 24 hours before the scan
  • Opiates and anticholinergics: Withhold for 48 hours before testing
  • Other interfering medications (nifedipine, indomethacin, octreotide, theophylline, phentolamine, isoproterenol, progesterone): Withhold for 24 hours
  • Nicotine and alcohol: Avoid prior to testing

Clinical Context and Pitfalls

The 24-hour withholding period for benzodiazepines is specifically designed to prevent false-positive diagnoses of functional gallbladder disorder. When benzodiazepines are present during CCK stimulation, they can artificially reduce the GBEF below the abnormal threshold of <38%, leading to unnecessary cholecystectomy in patients with normal gallbladder function.

Important caveat: While the FDA label for Xanax does not specifically mention HIDA scan interference 2, this reflects the drug label's focus on direct drug effects rather than diagnostic test interactions. The guideline evidence is definitive and takes precedence for procedural preparation.

Practical Implementation

For patients scheduled for HIDA scanning:

  • Discontinue alprazolam 24 hours before the scheduled scan time
  • Ensure the patient is fasting 4-6 hours (or overnight) before the procedure
  • Verify medication history carefully, as chronic benzodiazepine use may require longer washout
  • The scan should be performed on an outpatient basis when the patient is not acutely ill, as illness itself can affect GBEF 1

The evidence is clear and consistent across multiple guideline sources: benzodiazepines interfere with gallbladder function assessment and must be withheld to ensure accurate diagnostic results.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.